|
RPS6KB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.06749994691569E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.78920000000393E-05 |
| Normal-vs-Stage2 |
2.663900E-02 |
| Normal-vs-Stage3 |
7.263800E-03 |
| Normal-vs-Stage4 |
8.888200E-02 |
| Stage1-vs-Stage2 |
5.266800E-01 |
| Stage1-vs-Stage3 |
9.288000E-01 |
| Stage1-vs-Stage4 |
2.597200E-01 |
| Stage2-vs-Stage3 |
6.265200E-01 |
| Stage2-vs-Stage4 |
3.811400E-01 |
| Stage3-vs-Stage4 |
2.757800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00619999998663E-07 |
| Normal-vs-AfricanAmerican |
2.323300E-03 |
| Normal-vs-Asian |
1.031740E-04 |
| Caucasian-vs-AfricanAmerican |
4.932400E-01 |
| Caucasian-vs-Asian |
5.245000E-01 |
| AfricanAmerican-vs-Asian |
5.520600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.88809999998896E-06 |
| Normal-vs-Female |
2.85169999836299E-08 |
| Male-vs-Female |
8.075600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.575700E-03 |
| Normal-vs-Extreme_Weight |
1.361210E-03 |
| Normal-vs-Obese |
3.826600E-04 |
| Normal-vs-Extreme_Obese |
3.597400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.952400E-01 |
| Normal_Weight-vs-Obese |
7.871000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.097600E-01 |
| Extreme_Weight-vs-Obese |
5.696800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.797400E-01 |
| Obese-vs-Extreme_Obese |
4.794200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.32100000005408E-06 |
| Normal-vs-Age(41-60Yrs) |
1.5631000049865E-08 |
| Normal-vs-Age(61-80Yrs) |
1.678680E-03 |
| Normal-vs-Age(81-100Yrs) |
8.767400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.274380E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.766500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.804600E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608440E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.294500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.184800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87609999757754E-08 |
| Normal-VS-Type2 PRCC |
6.074500E-02 |
| Normal-VS-KIRP CIMP |
1.383140E-03 |
| Normal-VS-Unclassified PRCC |
3.620600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.982400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.648420E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.412800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.760400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.285400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.332300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.291700E-02 |
| Normal-vs-N1 |
6.201600E-03 |
| Normal-vs-N2 |
2.127200E-01 |
| N0-vs-N1 |
3.914200E-02 |
| N0-vs-N2 |
1.478000E-01 |
| N1-vs-N2 |
8.601600E-01 |
|
|
